Navigation Links


Enzymes in Medical Technology

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... that requires the use of cytochrome P450 (CYP) enzymes to convert the drug into the active metabolite. ... which is part of the CYP system and encodes the enzymes that are responsible for converting prasugrel ... associations for major cytochrome P450 enzymes in native and first- and third-generation ...

DSM and LibraGen Sign Agreement to Co-Develop Transaminases for Production of Chiral Amines

... enzyme discovery and development to identify new enzymes for efficient conversion of a large spectrum of ... DSM will produce the enzymes at industrial scale using DSM's fermentation ... platform, PluGbug(TM). LibraGen will sell the enzymes in kit form and both parties will use them for ...

Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796

... Clinically significant elevations of liver enzymes were observed in approximately eight percent of ... and ribavirin. In contrast, elevated liver enzymes were seen in only one percent of patients on standard of care. Elevations of liver enzymes appear to be transient in some patients. The U.S. ...

EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health

... -- EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it ... properties. EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann ...

Mutant Genes in High-Risk Childhood Leukemias Identified

... some high-risk ALL cases might arise from mutations in genes that produce enzymes called kinases, which function as biological on-off switches in cells," ... the researchers plan to identify mutations in kinase genes and other enzymes that underlie high-risk ALL, as well as explore how these abnormalities ...

Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

... Food and Drug Administration for maintenance treatment of patients with enzymes of the urea cycle. The Company recently announced results from its phase ... States. Patients with urea cycle disorders are deficient in one of the key enzymes that comprise the urea cycle, the body's primary vehicle for removing ...

Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme

... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze Technology is a novel drug ... with Baxter International Inc. Halozyme also has a number of different enzymes in its portfolio that target significant areas of unmet medical need. For ...

Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target

... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... with Baxter International Inc. Halozyme also has a number of different enzymes in its portfolio that target significant areas of unmet medical need. For ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... events (major and clinically relevant non-major) and elevated liver enzymes and/or bilirubin, which might be indicative of hepatic toxicity. Secondary ... There were no significant differences in patients with elevated liver enzymes or bilirubin across all treatment groups, and there were no significant ...

New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation

... events (major and clinically relevant non-major) and elevated liver enzymes and/or bilirubin. Secondary endpoints included major adverse ... no significant differences in the numbers of patients with elevated liver enzymes or bilirubin across all treatment groups. Although the study was not ...

New Insight Into the Controls on a Go-To Enzyme

... to calpain and inhibiting it --- essentially ignoring other highly similar enzymes in the cell. In an article published in the November 20, 2008, ... recognize only calpains, rather than mistakenly attach to other similar enzymes in the cell. Furthermore, the researchers discovered how ...

New Data Show In Vitro Potency of Doripenem Against Resistant Bacteria

... enzymes, respectively. Both ESBL and AmpC Beta-lactamase are enzymes that destroy cephalosporins and other related antibiotics. Approximately, ... Enterobacter spp., indole-positive Proteae and Serratia spp. ESBL and AmpC enzymes had little impact on doripenem MIC(50) potencies (up to two-fold). ...

Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models

... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... with Baxter International Inc. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...

Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial

... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... with Baxter International Inc. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...

Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability

... candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... with Baxter International Inc. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...

Research Explains How Advanced Prostate Cancer Becomes Resistant to Androgen-Deprivation Therapy

... Mostaghel said. "As we develop new drug targets, we will need to focus on enzymes that seem to be active in the tumor tissue itself. This offers a new way ... of progesterone to testosterone precursors, as well as inhibitors of enzymes that perform subsequent steps in testosterone production: AKR1C3 and ...

Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors

... PCI-24781 has been shown to inhibit all forms of HDAC enzymes to target a broad range of cancer types, including colon, breast, ... About HDAC Inhibitors Histone deacetylases are a family of related enzymes important in managing a multitude of cellular functions. HDAC inhibitors ...

Baxter Presents Latest Clinical Trial Results of GAMMAGARD LIQUID Administered Subcutaneously

... of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze Technology is a novel drug ... injected drugs and fluids. The company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. ...

JAK2 Inhibitor Shows Potent Activity in Cells From MPD Patients

... of disease cells. Extensive screening against a panel of 73 kinase enzymes indicates that CYT387 possesses selectivity for JAK2, potentially ... and New York and specializes in discovering new molecules that can inhibit enzymes known as kinases, an exciting new class of drugs. ...

NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020

... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and response to cigarette smoke exposure. ... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and response to cigarette smoke exposure. ...

Hyperion Therapeutics Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of GT4P in Patients With Urea Cycle Disorders

... in the U.S. Patients with UCDs lack or are deficient in one of the key enzymes that comprise the urea cycle, the body's primary vehicle for removing ... and associated encephalopathy in patients with deficiencies in enzymes of the urea cycle. The most common adverse reactions are vomiting (9%), ...

VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)

... selective inhibitor of SHP-1 and SHP-2. Inhibition of these key regulatory enzymes results in the up-regulation of the response to immunologic stimuli ... preclinical studies conducted at the Cleveland Clinic. These intracellular enzymes are involved in signaling pathways of many receptor-linked tyrosine ...

Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer

... of products is based on intellectual property covering the family of human enzymes known as hyaluronidases. The company's Enhanze(TM) Technology is a novel ... Baxter Healthcare Corporation. The Company also has a number of different enzymes in its portfolio that are targeting significant areas of unmet need. Safe ...

NicOx Reports TOPIGEN to Advance TPI-1020 Into Phase 2 for COPD Following Promising Clinical Results

... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and is frequently a response to exposure to ... recruitment of inflammatory cells such as neutrophils (cells releasing enzymes that destroy lung tissue) and response to exposure to cigarette smoke. ...

CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia

... and pharmacodynamic studies to evaluate the inhibition of HDAC enzymes in AML cells from patients treated with belinostat. Evaluation of the ... a new mechanistic class of anti-cancer therapeutics that target HDAC enzymes and have been shown to arrest growth of cancer cells (including drug ...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

... tumor bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy. Preclinical and clinical studies support that OPAXIO metabolism by lung cancer ...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

... and lower respiratory tract were the only other infections or adverse events that occurred in 5 percent or more of patients. Elevations of liver enzymes and bilirubin were noted, but were not characteristic of drug-induced liver injury and were judged to be not related to vicriviroc. These infections ...

Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

... genetics of ALL, pharmacogenetic traits of patients and pharmacodynamic principles. "We prospectively determined the activity of drug-metabolizing enzymes of each patient and adjusted the dosage of chemotherapy accordingly," said Mary Relling, Pharm.D., chair of the St. Jude Department of Pharmaceutical ...

Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients

... reported in clinical studies were upper respiratory tract infection, nasopharyngitis, headache, hypertension and increased ALT. Increases in liver enzymes (ALT and AST) were seen in patients; these increases were generally mild and reversible, with no evidence of hepatic injuries. Laboratory changes, ...

Paclitaxel Poliglumex (OPAXIO(TM)) Added to Cisplatin and Radiation Produces 45% Pathologic Complete Remissions in Patients With Esophageal Cancer

... tumor bed allowing significantly more of the dose of chemotherapy to localize in the tumor than with standard paclitaxel. Once inside the tumor cell, enzymes metabolize the protein polymer, releasing the paclitaxel chemotherapy. Preclinical and clinical studies support that OPAXIO metabolism by lung cancer ...

Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences

... immunodeficiency virus (HIV). Our research and development efforts focus on nucleos(t)ide analogs, a class of compounds which act to inhibit the enzymes required for viral replication. We currently have three clinical-stage product candidates: R7128, a nucleoside analog for chronic HCV infections, has ...

Horizon Therapeutics' HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain

... widely used drugs in the world for the treatment of arthritis and pain and are a major cause of GI complications, including ulcers. NSAIDs block enzymes and reduce prostaglandins throughout the body and as a consequence, ongoing inflammation, pain, and fever are reduced. Because the prostaglandins ...

Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting

... dyspnea have been reported in patients after Leukine administration. Leukine has induced the elevation of serum creatinine or bilirubin and hepatic enzymes in some patients. Monitoring of renal and hepatic function in patients with preexisting renal or hepatic dysfunction is recommended at least every ...

Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients

... reported in clinical studies were upper respiratory tract infection, nasopharyngitis, headache, hypertension and increased ALT. Increases in liver enzymes (ALT and AST) were seen in patients; these increases were generally mild and reversible, with no evidence of hepatic injuries. Laboratory changes, ...

TriLink Launches CleanAmp(TM) dNTPs for Hot Start PCR

... whereas CleanAmp(TM) dNTPs will be a more general solution. Either product will provide a very cost effective solution when compared to the modified enzymes available on the market." About TriLink TriLink BioTechnologies, Inc. manufactures custom oligonucleotides, nucleoside triphosphates and ...

Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome

... to a series of clinical and pre-clinical compounds that inhibit the enzymatic activity of members of the phospholipase (PLA2) family - a group of enzymes responsible for the release of arachidonic acid and subsequent production of leukotrienes¿ prostacyclins and other mediators of inflammation. These ...

Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications

... and large proteins across the endothelial membrane in the BBB. NeuroTrans(TM) has also been conjugated to a variety of protein drugs, including enzymes and growth factors, without interfering with their therapeutic functions. About Raptor Pharmaceuticals Corp. Raptor Pharmaceuticals ...

Autism Genes Discovered; Help Shape Connections Among Brain Cells

... first study. The other gene cluster impacted by copy number variations belongs to the ubiquitin degradation pathway. Ubiquitins are a class of enzymes that eliminate connections among nerve cells, and are involved with processing and degrading neuronal cell-adhesion molecules -- thus linking the ...

ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients

... that the next generation of therapies for treatment of HCV will include small molecules, such as ANA598, that directly act upon specific viral enzymes to inhibit viral replication. These new therapies are expected to improve overall therapy by increasing cure rates and potentially improving ...

Hyperion Therapeutics Announces Results for Phase II Study in Urea Cycle Disorders

... of metabolism present in an estimated 1 in 10,000 births in the United States. Patients with urea cycle disorders are deficient in one of the key enzymes that comprise the urea cycle, the body's primary vehicle for removing ammonia, a potent neurotoxin, from the bloodstream. Onset may occur at any age ...
Other Contentsaspirinaspirinaspirinaspirinchildrenchildrenchildrenchildrenchildrenchildrenchildrenchildrenchildrenastigmatismastigmatismasymptomaticasymptomaticasymptomaticasymptomaticataxiaataxiaataxiaatelectasis
(Date:11/25/2009)... Kent State University assistant professors recent...dation (NSF) to continue research beneficial to un...l $890,000. , Christopher Blackwood, assistant p... was awarded grants to support two separate resear...ling Litter Decomposer Communities and Functions f...
(Date:11/24/2009)... thousands of years it has been prescribed by trad...ents from headaches and stomach pain to fever and ...castle University have been able to scientifically...enata otherwise known as Brazilian mint. , Test...team led by researcher Graciela Rocha was able to ...
(Date:11/24/2009)...ket science is opening new doors to understanding ... the hearing of a marine mammal or if they hear i...zed X-ray scanners that NASA uses to detect flaws ... is now allowing scientists to peek inside the gia...ed three-dimensional replicas of a whale,s hearing...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 1Council for American Medical Innovation to Host Capitol Hill Breakfast Briefing on Education and Immigration 3A The Building Blocks of Innovation 56116 2Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 1Optimer Pharmaceuticals to Present at September 2009 Investor Conferences 13820 2IMIA Interpreter Association Appoints Brazil Representative 56110 1IMIA Interpreter Association Appoints Brazil Representative 56110 2
(Date:11/26/2009)...RINCETON,N.J.,Nov.27/PRNewswire/--Thediabetespopul...5yearsandannualmedicalspendingonthediseaseisprojec...ngtoastudypublishedintheDecemberissueof DiabetesCa...P),aprogramofNovoNordisk,commissionedtheanalysisby...theforecast,thenumberofAmericanslivingwithdiabetes...
(Date:11/26/2009)... No more letters from the North Po...lized text messages from Santa , ...increase operational efficiencies at the North Pol... keep children all over the globe informed of his ... Santa’s research department have identified...
(Date:11/25/2009)...DINA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmost...tachiropractorcanalsogivepatientsthehelptheyneed.T...eyourjaw(mandible)contacts/connectswithyourskull(t...dwithTMJdysfunctionarepainwithchewing,clickingorpo...MJdysfunctionincluding:headaches,fatigue,sleepdist...
(Date:11/25/2009)...ONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingme...iorsinthegreaterLongBeachareathankstoFaithInAction...denceatHome(IAH),adivisionofSCANHealthPlan.Formore...fvolunteerstodeliverwarmThanksgivingmealstoseniors...thLosAngelesandsurroundingcities. ,, "Ourwarmho...
(Date:11/25/2009)...rm survivors of testicular cancer who were treated... side effects, including neurological side effects... treated with chemotherapy, according to a new stu... the National Cancer Institute . , Marianne Bryd...University Hospital, in Bergen, Norway, and collea...
Breaking Medicine News(10 mins):Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
Other TagsawareawarerefusedloweredDadsempowercupcupcupregularlyOther Tagswant 2want 3want 4want 5want 6want 7want 8want 9want 10cope 2cope 3cope 4cope 5cope 6cope 7cope 8cope 9cope 10how 2how 3how 4how 5how 6how 7how 8how 9how 10meditation 2meditation 3fight 2fight 3fight 4fight 5fight 6fight 7fight 8fight 9fight 10alternative 2alternative 3alternative 4alternative 5alternative 6alternative 7alternative 8alternative 9alternative 10mind 2mind 3mark 2mark 3historic 2prematurely 2